Mesoblast (ASX:MSB) Total Stockholders Equity : A$760.04 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Mesoblast Total Stockholders Equity?

Mesoblast's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$760.04 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Mesoblast's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.75. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Mesoblast's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.24.

Mesoblast Total Stockholders Equity Historical Data

The historical data trend for Mesoblast's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesoblast Total Stockholders Equity Chart

Mesoblast Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

692.72

795.97

760.47

707.29

747.74

Mesoblast Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															722.29	747.74	-	760.04	-

Mesoblast (ASX:MSB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Mesoblast's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(760.044	-	0)	/	1014.8
	=	0.75

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Mesoblast's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(17.009	+	165.257)	/	760.044
	=	0.24

Mesoblast Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Mesoblast's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Mesoblast (ASX:MSB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (ASX:MSB) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

MEOBF:USA MESO:USA LWB:Germany

Address

Level 38, 55 Collins Street, Melbourne, VIC, AUS, 3000

Website

https://www.mesoblast.com

Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.